Post-Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Kinetics and Protection Duration

Clin Infect Dis. 2022 Aug 24;75(1):e924-e925. doi: 10.1093/cid/ciab984.

Chloé Dimeglio^{1

2}, Fabrice Herin^{3

4}, Isabelle Da-Silva¹, Marion Porcheron¹, Guillaume Martin-Blondel^{2

5}, Sabine Chapuy-Regaud¹, Jacques Izopet^{1

2}

¹ HU Toulouse, Hôpital Purpan, Virology Laboratory, Toulouse, France.
² INSERM UMR1291-CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), Toulouse, France.
³ Occupational Diseases Department, Toulouse University Hospital, Toulouse, France.
⁴ UMR1295, Unité Mixte INSERM-Université Toulouse III Paul Sabatier, Centre for Epidemiology and Research in Population Health Unit (CERPOP), Toulouse, Franceand.
⁵ Infectious and Tropical Diseases Department, Toulouse University Hospital, Toulouse, France.

No abstract available

MeSH terms